Molecular pathogenesis of human CD59 deficiency

Area of Science:

• Genetics and Molecular Biology
• Immunology
• Neuroscience

Background:

• CD59 is a crucial complement regulatory protein.
• Congenital CD59 deficiency leads to severe neurological and hematological disorders.
• Four specific mutations in CD59 have been identified in affected individuals.

Purpose of the Study:

• To comprehensively characterize the molecular consequences of four known CD59 mutations.
• To investigate the effects of these mutations on CD59 expression, localization, glycosylation, secretion, and function.
• To understand the pathogenic mechanisms underlying CD59 deficiency.

Main Methods:

• Cloning and plasmid insertion of four CD59 mutants (p.Cys64Tyr, p.Asp24Val, p.Asp24Valfs*, p.Ala16Alafs*).
• Analysis of protein expression, cell surface localization, and intracellular detection using immunolabeling (myc-tagged and anti-CD59 antibodies).
• Western blot analysis for glycosylation and secretion patterns; assessment of Membrane Attack Complex (MAC)-dependent cell lysis.

Main Results:

• Two mutants (p.Cys64Tyr, p.Asp24Val) showed cell surface expression but were not detected by anti-CD59 antibodies.
• Two frameshift mutants (p.Asp24Valfs*, p.Ala16Alafs*) were only detected intracellularly.
• All four mutants failed to inhibit MAC formation and significantly increased MAC-dependent cell lysis compared to wild-type CD59.

Conclusions:

• All four characterized CD59 mutations result in nonfunctional CD59 proteins.
• Two mutants are expressed on the cell surface, potentially mediating non-MAC-related functions.
• Two mutants are retained intracellularly, and distinct secretion patterns may contribute to disease pathogenesis.